Cyient DLM Limited reported a 118.2% year-on-year increase in consolidated net profit to ₹16.3 crore for the quarter ended June 30, 2026, driven by robust demand in aerospace and industrial segments that pushed its order book to a record high of ₹2,598.9 crore. The integrated Electronics Manufacturing Solutions (EMS) provider recorded consolidated revenue from operations of ₹373.8 crore, a 34.3% rise from the same period last year, while maintaining a strong book-to-bill ratio of 1.5x. This performance underscores the company’s strategic shift toward high-reliability sectors and emerging opportunities in AI infrastructure and robotics, providing significant revenue visibility for FY27 and beyond.

Consolidated Financial Performance

The company’s EBITDA grew 56.2% year-on-year to ₹39.2 crore, with margins expanding to 10.5%, marking the fourth consecutive quarter of double-digit EBITDA margins. Profit after tax (PAT) margins stood at 4.4%, expanding 168 basis points YoY. Order intake for the quarter was ₹551.9 crore, resulting in a book-to-bill ratio of 1.5x. Free cash flow was recorded at -₹17.1 crore, reflecting strategic investments in inventory build-up to mitigate supply chain disruptions from geopolitical tensions in West Asia. The following table summarises the key consolidated financial metrics:

Standalone Financial Performance

Standalone revenue from operations for the quarter ended June 30, 2026, stood at ₹282.9 crore, compared to ₹206.3 crore in the corresponding period of the previous year. Standalone net profit after tax for the period was ₹16.7 crore, up from ₹11.3 crore in Q1FY26. Basic and diluted earnings per share (EPS) for the standalone entity were reported at ₹2.10 for the quarter.

Operational Highlights and Strategic Roadmap

Cyient DLM operates primarily in the Electronic Manufacturing Services segment. The quarter saw strong momentum in Aerospace (42% of revenue) and Industrial (32% of revenue) segments, which delivered year-on-year growth of 40% and 90% respectively. Management outlined a phased "Strengthen, Expand, Transform" strategy. The current "Strengthen" phase focuses on core industries with 9–11% EBITDA margins. The "Expand" phase (FY27–FY29) targets entry into robotics and AI data centres, aiming for 11–13% margins. The final "Transform" phase (FY30 onwards) involves building product platforms to achieve 13–18% margins.

Rajendra Velagapudi, Managing Director and CEO, attributed the performance to disciplined execution and healthy demand, highlighting the completion of key leadership hires, including Rama Alapati as Chief Strategy and Growth Officer. The company also expanded its build-to-specifications lab from 6,000 to 15,000 square feet and completed Nadcap certification for cable harness assembly at its Mysore unit.

What the Numbers Show

The divergence between revenue growth (34.3%) and EBITDA growth (56.2%) indicates significant operating leverage, driven by better revenue mix and disciplined cost management. While working capital days increased to 161 days from 145 days in Q4FY26 due to inventory buildup, this is a strategic buffer against ongoing West Asia supply chain disruptions rather than a collection issue, as days sales outstanding remained stable at 77 days. The record order book of ₹2,598.9 crore provides substantial visibility, reducing reliance on volatile new business wins in the near term.

Regulatory Disclosure

In accordance with Regulation 46 of the SEBI LODR Regulations 2015, Cyient DLM Limited disclosed the recording of the Earnings Conference Call held on July 21, 2026. S Krithika, Company Secretary and Compliance Officer, confirmed the upload of the transcript and recording to the company website.

Cyient DLM announced that Yadama Muralidhar ceased to be a Non-Executive Independent Director on July 20, 2026, upon the completion of his tenure. The company confirmed that the change occurred at the close of business hours. Consequently, Muralidhar also ceased to be a member of the Audit Committee, Risk Management Committee, and ESG and CSR Committee of the company.

The Board of Directors and management expressed their appreciation for Muralidhar's contributions during his tenure. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The cessation was due to the completion of the director's tenure and was not attributable to any other reason. The company stated that there are no other material reasons for the change in board composition.

The following table details the event information: